➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Merck
Medtronic
Mallinckrodt
Express Scripts
Boehringer Ingelheim

Last Updated: July 24, 2021

DrugPatentWatch Database Preview

Details for Patent: 8,915,888


Email this page to a colleague

« Back to Dashboard

Summary for Patent: 8,915,888
Title:Dosing and drive mechanism for drug delivery device
Abstract: The present invention relates to drive mechanisms suitable for use in drug delivery devices, in particular pen-type injectors, wherein a number of pre-set doses of medicinal product can be administered. In particular, the present invention relates to such drug delivery devices where a user may activate the drug delivery device.
Inventor(s): Boyd; Malcolm (Leamington Spa, GB), Letham; Richard (Kingston Upon Thames, GB), Plumptre; David (Worcerstershire, GB), Veasey; Robert (Leamington Spa, GB), May; James (Earlsdon, GB), Jones; Matthew (Warwickshire, GB), Ghazaros; Samuel (Bristol, GB)
Assignee: Sanofi-Aventis Deutschland GmbH (Frankfurt am Main, DE)
Application Number:12/466,581
Patent Claim Types:
see list of patent claims
Delivery; Device; Formulation; Compound; Dosage form; Use;

Drugs Protected by US Patent 8,915,888

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,915,888

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
06023961Nov 17, 2006

International Family Members for US Patent 8,915,888

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 063838 ⤷  Free Forever Trial
Australia 2007321446 ⤷  Free Forever Trial
Brazil PI0719009 ⤷  Free Forever Trial
Canada 2669363 ⤷  Free Forever Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
McKesson
Johnson and Johnson
McKinsey
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.